clinical trial · NCT04693429
Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+
Laboratorios Sophia S.A de C.V.·phase1·completed·n = 22
SafetyTolerabilityOcular SurfaceOcular ComfortBepotastine Besilate
brief summary
Clinical phase I, controlled, non comparative, open, single center study evaluating the safety and tolerability of ophthalmic solution PRO-172 when applied on the ocular surface of healthy volunteers.
started
Sep 24, 2020
primary completion
Nov 27, 2020
completion
Dec 8, 2020
last updated
Jul 16, 2025
official title
Phase I Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution, Manufactured by Laboratorios Sophia, S.A. de C.V., When Applied on the Ocular Surface of Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol